Jump to content

Welcome to the new Traders Laboratory! Please bear with us as we finish the migration over the next few days. If you find any issues, want to leave feedback, get in touch with us, or offer suggestions please post to the Support forum here.

  • Welcome Guests

    Welcome. You are currently viewing the forum as a guest which does not give you access to all the great features at Traders Laboratory such as interacting with members, access to all forums, downloading attachments, and eligibility to win free giveaways. Registration is fast, simple and absolutely free. Create a FREE Traders Laboratory account here.

Search the Community

Showing results for tags 'valuation'.



More search options

  • Search By Tags

    Type tags separated by commas.
  • Search By Author

Content Type


Forums

  • Welcome to Traders Laboratory
    • Beginners Forum
    • General Trading
    • Traders Log
    • General Discussion
    • Announcements and Support
  • The Markets
    • Market News & Analysis
    • E-mini Futures
    • Forex
    • Futures
    • Stocks
    • Options
    • Spread Betting & CFDs
  • Technical Topics
    • Technical Analysis
    • Automated Trading
    • Coding Forum
    • Swing Trading and Position Trading
    • Market Profile
    • The Wyckoff Forum
    • Volume Spread Analysis
    • The Candlestick Corner
    • Market Internals
    • Day Trading and Scalping
    • Risk & Money Management
    • Trading Psychology
  • Trading Resources
    • Trading Indicators
    • Brokers and Data Feeds
    • Trading Products and Services
    • Tools of the Trade
    • The Marketplace
    • Commercial Content
    • Listings and Reviews
    • Trading Dictionary
    • Trading Articles

Calendars

There are no results to display.


Find results in...

Find results that contain...


Date Created

  • Start

    End


Last Updated

  • Start

    End


Filter by number of...

Joined

  • Start

    End


Group


First Name


Last Name


Phone


City


Country


Gender


Occupation


Biography


Interests


LinkedIn


How did you find out about TradersLaboratory?


Vendor


Favorite Markets


Trading Years


Trading Platform


Broker

Found 4 results

  1. ntrader

    Google Inc.

    Google Inc., builds products and provides services to organize the information and make it universally accessible and useful. It provides Search, a service that delivers relevant search results in response to user queries; Product Listing Ads that offer product information. BALANCE SHEET Google Inc. earned $3.3 billion, or $9.94 per share, during the opening three months of the year. That was a 16 percent increase from $2.9 billion, or $8.75 per share, last year. If not for certain expenses, Google said it would have earned $11.58 per share. Revenue climbed 31 percent from last year to $14 billion. After subtracting advertising commissions, Google's revenue totaled $11 billion — about $335 million below analyst estimates. The first-quarter numbers show that a recent decline in Google's average ad prices is easing. That's an indication that marketers are starting to pay more for the ads that Google distributes to smartphones and tablet computers. Google's average price, or the "cost per click" to advertisers, has fallen from the previous year in six consecutive quarters, including the opening three months of the year. GOOG PE stands at 24.83 below the industry average of 67.86 and above the S&P 500 average of 16.70. The stock is currently trading 9% below its intrinsic value of $874.82 this suggests that the stock is undervalued at these levels. GOOG's current Price/Sales of 5.03 is above the average of its industry of 2.33. The beta of 1.15 implies higher volatility of the stock with respect to the S&P 500. GOOG’s Total Debt/Equity is 7.70 and is acceptable for our model. At the end of the quarter, Google had $50.1 billion in cash and cash equivalents. The company pays no dividend. I believe GOOG is still a buy
  2. Walgreen Company is the world's largest drug retailer, operates retail drug store and general merchandise. It is engaged in the retail sale of prescription and non-prescription drugs and general merchandise. The stock closed the last trading session at $40.13. In the past year, the stock has hit a 52-week low of $28.53 and 52-week high of $42.00. Technical indicators for the stock are neutral. WAG has a market cap of $37.93 billion and is part of the services sector. BALANCE SHEET Net earnings for the first quarter ended November 30, 2012 were $413 million or $.43 per diluted share. This was a 25.5% decrease in net earnings over the same quarter last year. Quarter net earnings and net earnings per diluted share, respectively, was $59 million, or $.06 per diluted share, in acquisition-related amortization, $34 million, or $.04 per diluted share. Net sales for the quarter ended November 30, 2012 decreased by 4.6% to $17.3 billion. VALUATION WAG PE stands at 18.16 above the industry’s average of 17.26. The stock is currently trading 6% below its intrinsic value of $42.80 this suggests that the stock is undervalued at these levels. WAG’s current Price/Sales of 0.54 is at the average of its industry of 0.52. The beta of 1.28 implies higher volatility of the stock with respect to the S&P 500. The firm pays a 2.6% dividend yield. WAG’s Total Debt/Equity is 34.70% The company has demonstrated neutral technical signs, the company stands on very sound financial footing but lower sales makes us cautious at current price level. WAG stock is 8.43% higher year to date. My overall score for WAG is 5.00/10.00 I am neutral on the stock.
  3. This thread is for those who like to discuss about the Fundamental Valuation (Relative valuation / Discounted Cash Flow valuation) of stocks listed on NYSE. I am waiting for your thoughts in this thread and their usefulness in trading. We all know valuation is done by Research analyst and if the current market price is below (above) than the Intrinsic value of the stock, then the stock is Undervalued (overvalued) and we do the trading accordingly. Awaiting more inputs to this thread so that it helps in trading decision making. Happy Learning
  4. Exxon Mobil Corporation engages in the exploration and production of crude oil and natural gas, and manufacture of petroleum products. Last Price: $88.36 Highlights: Exxon Mobil is the world's largest publicly traded integrated oil company and the largest producer of natural gas in the United States with a daily production of 3,712 mmcf. The stock closed yesterday’s trading session at $88.36. In the past year, the stock has hit a 52-week low of $77.13 and 52-week high of $93.67. Technical indicators for the stock are bullish. XOM has a market cap of $397.80 billion and is part of the basic materials sector. BALANCE SHEET XOM profit in the fourth quarter was $9.95 billion, or $2.20 per share, compared with $9.4 billion, or $1.97 per share, in the same period a year earlier. Oil and gas output fell 5.2 percent to 4.29 million barrels oil equivalent per day, Exxon said. Profit at Exxon's exploration and production business fell 12% to $7.76 billion. At its chemicals unit, profit more than doubled to $958 million, and refining earnings were $1.77 billion, up sharply from $425 million a year earlier. VALUATION XOM PE stands at 9.11 below the industry’s average of 9.87. The stock is currently trading 6% below its intrinsic value of $93.90 this suggests that the stock is undervalued at these levels. XOM's current Price/Sales of 0.88 is above the average of its industry of 0.87. The beta of 0.85 implies lower volatility of the stock with respect to the S&P 500. The firm pays a 2.60% annual dividend yield. XOM’s Total Debt/Equity is 8% and is acceptable for our model. My view: The company has demonstrated neutral technical signs. The current P/E ratio of 9.11 and dividend yield of 2.60% makes this stock very attractive for value investors. XOM stock is 4.29% higher year to date. I will buy the stock and keep it my portfolio as a long term investment and not for trading.
×
×
  • Create New...

Important Information

By using this site, you agree to our Terms of Use.